ZFP69B
Zinc finger protein 69 homolog B
Also known as: FLJ34293, ZF69B_HUMAN, ZKSCAN23B, ZNF643, ZSCAN54B
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q9UJL9
- Gene
- ZFP69B
- Ensembl
- ENSG00000187801
- Chromosome
- 1
- Canonical length
- 534 aa
- Protein class
- Predicted intracellular proteins, Transcription factors
- Subcellular location
- Nucleoplasm,Cytosol
OverviewNCBI Gene
Predicted to enable DNA-binding transcription factor activity, RNA polymerase II-specific and RNA polymerase II transcription regulatory region sequence-specific DNA binding activity. Involved in Golgi organization. Located in nucleolus. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
534 residues, UniProt reviewed canonical sequence.
>Q9UJL9|ZFP69B
1 MLQQLLITLP TEASTWVKLR HPKAATERVA LWEDVTKMFK AEALLSQDAD ETQGESLESR
61 VTLGSLTAES QELLTFKDVS VDFTQEEWGQ LAPAHRNLYR EVMLENYGNL VSVGCQLSKP
121 GVISQLEKGE EPWLMERDIS GVPSSDLKSK TKTKESALQN DISWEELHCG LMMERFTKGS
181 SMYSTLGRIS KCNKLESQQE NQRMGKGQIP LMCKKTFTQE RGQESNRFEK RINVKSEVMP
241 GPIGLPRKRD RKYDTPGKRS RYNIDLVNHS RSYTKMKTFE CNICEKIFKQ LIHLTEHMRI
301 HTGEKPFRCK ECGKAFSQSS SLIPHQRIHT GEKPYECKEC GKTFRHPSSL TQHVRIHTGE
361 KPYECRVCEK AFSQSIGLIQ HLRTHVREKP FTCKDCGKAF FQIRHLRQHE IIHTGVKPYI
421 CNVCSKTFSH STYLTQHQRT HTGERPYKCK ECGKAFSQRI HLSIHQRVHT GVKPYECSHC
481 GKAFRHDSSF AKHQRIHTGE KPYDCNECGK AFSCSSSLIR HCKTHLRNTF SNVVLocalizationUniProt · AlphaFold · HPA
Whether an antibody against ZFP69B can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.49
- Highest tissue expression
- 2.1 nTPM
Expression across tissuesHPA
Tissue
- cerebral cortex: 2.1 nTPM
- thymus: 1.8 nTPM
- tonsil: 1.8 nTPM
- appendix: 1.6 nTPM
- retina: 1.4 nTPM
- endometrium: 1.3 nTPM
Single-cell type
- brain inhibitory neurons: 13 nCPM
- brain excitatory neurons: 9.1 nCPM
- oligodendrocyte progenitor cells: 8.3 nCPM
- differentiating spermatogonia: 8.1 nCPM
- neutrophils: 7.8 nCPM
- plasma cells: 7.3 nCPM
Immune cell
- T-reg: 1.5 nTPM
- MAIT T-cell: 1.2 nTPM
- naive CD4 T-cell: 1.2 nTPM
- naive CD8 T-cell: 1 nTPM
- gdT-cell: 0.9 nTPM
- intermediate monocyte: 0.7 nTPM
Brain region
- cerebral cortex: 10 nTPM
- amygdala: 7.8 nTPM
- basal ganglia: 7.1 nTPM
- hippocampal formation: 7 nTPM
- white matter: 6.7 nTPM
- pons: 6.5 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.46
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.68
- DepMap mean gene effect
- -0.1
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 6% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Molecular functions
- DNA-binding transcription factor activity, RNA polymerase II-specific
- RNA polymerase II transcription regulatory region sequence-specific DNA binding
- zinc ion binding
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads ZFP69B as an antibody target. Whether an autoantibody or antibody against ZFP69B could matter depends on whether native ZFP69B is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
ZFP69B is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label ZFP69B as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...